Evidence map›Paper›PMID 31852750›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.

Satoshi Yoshimura, Rodolfo Thome, Shingo Konno, Elisabeth R Mari, Javad Rasouli, Daniel Hwang, Alexandra Boehm, Yanhua Li, Guang-Xian Zhang, Bogoljub Ciric and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The World according to IL-9.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  9. Article
  10. Article
  11. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Satoshi YoshimuraDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.
Rodolfo ThomeDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0001-7627-4137
Shingo KonnoDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-8731-0663
Elisabeth R MariDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.
Javad RasouliDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0001-7677-5636
Daniel HwangDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-6071-8271
Alexandra BoehmDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-9820-580X
Yanhua LiDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.
Guang-Xian ZhangDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.
Bogoljub CiricDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107.
Abdolmohamad RostamiDepartment of Neurology, Jefferson Hospital for Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107 a.m.rostami@jefferson.edu.ORCID 0000-0003-0716-2726
Thomas Jefferson University · US

Funding

Mechanisms of GM-CSF effect in CNS autoimmune demyelinationR01AI124386 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI ROSTAMI, A.M. · 2017 to 2021
$1.9M
The role of IL-27 in iv tolerance in EAER01AI106026 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI ROSTAMI, A.M. · 2014 to 2018
$1.9M
The Role of GM-CSF in the Pathogenesis of Multiple SclerosisR01NS088729 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI ROSTAMI, A.M. · 2014 to 2018
$1.7M
NIAID NIH HHS R01 AI106026NIAID NIH HHS R01 AI124386NINDS NIH HHS R01 NS088729
6 · The paper itself

Abstract

Multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) are inflammatory diseases of the CNS in which Th17 cells play a major role in the disease pathogenesis. Th17 cells that secrete GM-CSF are pathogenic and drive inflammation of the CNS. IL-9 is a cytokine with pleiotropic functions, and it has been suggested that it controls the pathogenic inflammation mediated by Th17 cells, and IL-9R

Indexed as

Adoptive TransferAnimalsAutoimmunityCells, CulturedCentral Nervous SystemDendritic CellsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalGranulocyte-Macrophage Colony-Stimulating FactorHumansInflammation MediatorsInterleukin-9MiceMice, Inbred C57BLMice, KnockoutMultiple SclerosisGranulocyte-Macrophage Colony-Stimulating FactorInflammation MediatorsInterleukin-9Receptors, Interleukin-9

Identifiers

PMID31852750
PMCPMC7197375
OpenAlexW2996577056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.